Beacon Pointe Advisors LLC Reduces Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Beacon Pointe Advisors LLC lowered its position in SPDR S&P Biotech ETF (NYSEARCA:XBIGet Rating) by 7.1% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 17,365 shares of the exchange traded fund’s stock after selling 1,333 shares during the period. Beacon Pointe Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $1,285,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also recently bought and sold shares of the company. MUFG Americas Holdings Corp boosted its position in SPDR S&P Biotech ETF by 73.5% in the first quarter. MUFG Americas Holdings Corp now owns 347 shares of the exchange traded fund’s stock valued at $31,000 after buying an additional 147 shares during the last quarter. CAPROCK Group Inc. purchased a new stake in SPDR S&P Biotech ETF in the second quarter valued at approximately $482,000. Jackson Hole Capital Partners LLC boosted its position in SPDR S&P Biotech ETF by 27.8% in the second quarter. Jackson Hole Capital Partners LLC now owns 1,840 shares of the exchange traded fund’s stock valued at $137,000 after buying an additional 400 shares during the last quarter. High Note Wealth LLC boosted its position in SPDR S&P Biotech ETF by 28.0% in the second quarter. High Note Wealth LLC now owns 12,753 shares of the exchange traded fund’s stock valued at $947,000 after buying an additional 2,792 shares during the last quarter. Finally, Cetera Advisor Networks LLC boosted its position in SPDR S&P Biotech ETF by 12.4% in the first quarter. Cetera Advisor Networks LLC now owns 35,660 shares of the exchange traded fund’s stock valued at $3,205,000 after buying an additional 3,935 shares during the last quarter.

SPDR S&P Biotech ETF Trading Up 0.0 %

Shares of NYSEARCA XBI opened at $81.00 on Thursday. SPDR S&P Biotech ETF has a 52 week low of $61.78 and a 52 week high of $120.53. The business’s 50 day moving average price is $80.46 and its 200 day moving average price is $79.21.

About SPDR S&P Biotech ETF

(Get Rating)

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Featured Articles

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.